撤回:ENKUR招募FBXW7使MYH9泛素化和降解,并进一步抑制MYH9诱导的β-连环蛋白去泛素化,从而阻断胃癌转移

IF 10.7 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
MedComm Pub Date : 2025-03-11 DOI:10.1002/mco2.70160
{"title":"撤回:ENKUR招募FBXW7使MYH9泛素化和降解,并进一步抑制MYH9诱导的β-连环蛋白去泛素化,从而阻断胃癌转移","authors":"","doi":"10.1002/mco2.70160","DOIUrl":null,"url":null,"abstract":"<p>J. Liu, Z. Liu, W.i Yan, et al., “ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-catenin to Block Gastric Cancer Metastasis,” <i>MedComm</i> 3, no. 4 (2022): e185, https://doi.org/10.1002/mco2.185.</p><p>The above article, published online on 25 November 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editors-in-Chief; the Sichuan International Medical Exchange &amp; Promotion Association (SCIMEA); and John Wiley &amp; Sons Australia, Ltd. The retraction has been agreed due to concerns raised by third parties. Further investigation by the publisher has found evidence of image manipulation in Figure 5G. The authors cooperated with the investigation and stated that they were unaware of any manipulation as they did not directly participate in the experiments presented in Figure 5G. They informed the journal that, due to laboratory limitations, an independent company conducted the EMSA experiments and provided them with the digital images of the results instead of original blots. The authors state that they had no reason to doubt the data's authenticity and did not notice irregularities in the images before submission. During the investigation, the authors explained that the company which conducted the EMSA experiments was not the same company stated in the article.</p><p>Additionally, a significant portion of the article's conclusions are based on experiments on the cell line BGC-823, reported as contaminated [1, 2]. The authors provided the STR profile of the cell line used in their study, and this was found to match the problematic cell line BGC-823 at RRID CVCL_3360. Accordingly, the article must be retracted as the editors and the publisher determined that a significant portion of the article's data is unreliable and consider its conclusions invalid. In light of the concerns identified in the course of the investigation, the authors have agreed to retract the article.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 3","pages":""},"PeriodicalIF":10.7000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70160","citationCount":"0","resultStr":"{\"title\":\"RETRACTION: ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-Catenin to Block Gastric Cancer Metastasis\",\"authors\":\"\",\"doi\":\"10.1002/mco2.70160\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>J. Liu, Z. Liu, W.i Yan, et al., “ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-catenin to Block Gastric Cancer Metastasis,” <i>MedComm</i> 3, no. 4 (2022): e185, https://doi.org/10.1002/mco2.185.</p><p>The above article, published online on 25 November 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editors-in-Chief; the Sichuan International Medical Exchange &amp; Promotion Association (SCIMEA); and John Wiley &amp; Sons Australia, Ltd. The retraction has been agreed due to concerns raised by third parties. Further investigation by the publisher has found evidence of image manipulation in Figure 5G. The authors cooperated with the investigation and stated that they were unaware of any manipulation as they did not directly participate in the experiments presented in Figure 5G. They informed the journal that, due to laboratory limitations, an independent company conducted the EMSA experiments and provided them with the digital images of the results instead of original blots. The authors state that they had no reason to doubt the data's authenticity and did not notice irregularities in the images before submission. During the investigation, the authors explained that the company which conducted the EMSA experiments was not the same company stated in the article.</p><p>Additionally, a significant portion of the article's conclusions are based on experiments on the cell line BGC-823, reported as contaminated [1, 2]. The authors provided the STR profile of the cell line used in their study, and this was found to match the problematic cell line BGC-823 at RRID CVCL_3360. Accordingly, the article must be retracted as the editors and the publisher determined that a significant portion of the article's data is unreliable and consider its conclusions invalid. In light of the concerns identified in the course of the investigation, the authors have agreed to retract the article.</p>\",\"PeriodicalId\":94133,\"journal\":{\"name\":\"MedComm\",\"volume\":\"6 3\",\"pages\":\"\"},\"PeriodicalIF\":10.7000,\"publicationDate\":\"2025-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70160\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedComm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mco2.70160\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedComm","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mco2.70160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

刘杰,刘志强,闫维怡,等,“ENKUR诱导FBXW7泛素化和降解MYH9并进一步抑制MYH9诱导的β-连环蛋白去泛素化抑制胃癌转移”,中国医学杂志,第3期。4 (2022): e185, https://doi.org/10.1002/mco2.185.The上述文章于2022年11月25日在线发表在Wiley在线图书馆(wileyonlinelibrary.com)上,经作者同意撤回;杂志总编;四川国际医学交流;促进会;约翰·威利&;澳大利亚之子有限公司由于第三方的担忧,双方同意撤回声明。出版商的进一步调查发现了图5G中图像处理的证据。作者配合调查,并表示他们不知道任何操纵,因为他们没有直接参与图5G所示的实验。他们告诉该杂志,由于实验室的限制,一家独立公司进行了EMSA实验,并向他们提供了结果的数字图像,而不是原始的斑点。作者表示,他们没有理由怀疑数据的真实性,在提交之前也没有注意到图像中的不规则之处。在调查过程中,作者解释说,进行EMSA实验的公司不是文章中所述的同一家公司。此外,文章结论的很大一部分是基于对被污染的细胞系BGC-823的实验得出的[1,2]。作者提供了他们研究中使用的细胞系的STR谱,发现这与有问题的细胞系BGC-823在RRID CVCL_3360上匹配。因此,当编辑和出版商确定文章的很大一部分数据不可靠并认为其结论无效时,文章必须被撤回。鉴于调查过程中发现的问题,作者同意撤回文章。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
RETRACTION: ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-Catenin to Block Gastric Cancer Metastasis

J. Liu, Z. Liu, W.i Yan, et al., “ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-catenin to Block Gastric Cancer Metastasis,” MedComm 3, no. 4 (2022): e185, https://doi.org/10.1002/mco2.185.

The above article, published online on 25 November 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editors-in-Chief; the Sichuan International Medical Exchange & Promotion Association (SCIMEA); and John Wiley & Sons Australia, Ltd. The retraction has been agreed due to concerns raised by third parties. Further investigation by the publisher has found evidence of image manipulation in Figure 5G. The authors cooperated with the investigation and stated that they were unaware of any manipulation as they did not directly participate in the experiments presented in Figure 5G. They informed the journal that, due to laboratory limitations, an independent company conducted the EMSA experiments and provided them with the digital images of the results instead of original blots. The authors state that they had no reason to doubt the data's authenticity and did not notice irregularities in the images before submission. During the investigation, the authors explained that the company which conducted the EMSA experiments was not the same company stated in the article.

Additionally, a significant portion of the article's conclusions are based on experiments on the cell line BGC-823, reported as contaminated [1, 2]. The authors provided the STR profile of the cell line used in their study, and this was found to match the problematic cell line BGC-823 at RRID CVCL_3360. Accordingly, the article must be retracted as the editors and the publisher determined that a significant portion of the article's data is unreliable and consider its conclusions invalid. In light of the concerns identified in the course of the investigation, the authors have agreed to retract the article.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信